Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it will host ...
If you’re living with advanced kidney disease, preparing for dialysis can feel overwhelming. One crucial decision is how your blood will be accessed for treatment. While there are different options, ...
In a recent study of older patients with end-stage kidney disease living in Europe, researchers found o ne-third received an ...
SOUTH JORDAN, Utah, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive 6-month findings from the ...
Please provide your email address to receive an email when new articles are posted on . Published findings report that, for vascular access in hemodialysis, the creation of an arteriovenous fistula ...
The increased risk for venous thromboembolism with an arteriovenous graft is one factor for clinicians and patients to consider in the choice of vascular access for hemodialysis. Among permanent ...
Briefly, this is how the AV fistula operation is performed: After ad-ministering local anesthesia, the surgeon makes a small incision over the patient’s radial pulse, mobilizes the radial artery, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results